Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity

被引：17

作者：

Carleton, B. C. ^{[1
,2
,3
]}

Ross, C. J. ^{[1
,2
,3
,4
]}

Bhavsar, A. P. ^{[1
]}

Amstutz, U. ^{[1
,2
,3
]}

Pussegoda, K. ^{[1
]}

Visscher, H. ^{[1
]}

Lee, J. W. ^{[1
,4
]}

Brooks, B. ^{[5
]}

Rassekh, S. R. ^{[1
,6
]}

Dube, M-P ^{[7
,8
]}

Hayden, M. R. ^{[1
,4
]}

机构：

[1] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada

[2] Univ British Columbia, Dept Pediat, Div Translat Therapeut, Vancouver, BC V6T 1W5, Canada

[3] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada

[4] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada

[5] British Columbia Childrens Hosp, Audiol & Speech Pathol Dept, Vancouver, BC V6H 3V4, Canada

[6] British Columbia Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol Bone Marrow Transplant, Vancouver, BC V6H 3V4, Canada

[7] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada

[8] Univ Montreal, Montreal, PQ, Canada

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷 / 03期

基金：

加拿大健康研究院;

关键词：

HEARING-LOSS; CHILDREN; VARIANTS;

D O I：

10.1038/clpt.2013.219

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：253 / 253

页数：1

共 5 条

[1] Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma [J].

Fouladi, Maryam ;

Chintagumpala, Murali ;

Ashley, David ;

Kellie, Stewart ;

Gururangan, Sridharan ;

Hassall, Tim ;

Gronewold, Lindsey ;

Stewart, Clinton F. ;

Wallace, Dana ;

Broniscer, Alberto ;

Hale, Gregory A. ;

Kasow, Kimberly A. ;

Merchant, Thomas E. ;

Morris, Brannon ;

Krasin, Matthew ;

Kun, Larry E. ;

Boyett, James M. ;

Gajjar, Amar .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3749-3755

[2] Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children [J].

Pussegoda, K. ;

Ross, C. J. ;

Visscher, H. ;

Yazdanpanah, M. ;

Brooks, B. ;

Rassekh, S. R. ;

Zada, Y. F. ;

Dube, M-P ;

Carleton, B. C. ;

Hayden, M. R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) :243-251

[3] Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [J].

Ross, Colin J. D. ;

Katzov-Eckert, Hagit ;

Dube, Marie-Pierre ;

Brooks, Beth ;

Rassekh, S. Rod ;

Barhdadi, Amina ;

Feroz-Zada, Yassamin ;

Visscher, Henk ;

Brown, Andrew M. K. ;

Rieder, Michael J. ;

Rogers, Paul C. ;

Phillips, Michael S. ;

Carleton, Bruce C. ;

Hayden, Michael R. .

NATURE GENETICS, 2009, 41 (12) :1345-U118

[4] ENHANCED CIS-PLATINUM OTOTOXICITY IN CHILDREN WITH BRAIN-TUMORS WHO HAVE RECEIVED SIMULTANEOUS OR PRIOR CRANIAL IRRADIATION [J].

WALKER, DA ;

PILLOW, J ;

WATERS, KD ;

KEIR, E .

MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (01) :48-52

[5] The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer [J].

Yang, J. J. ;

Lim, J. Y. S. ;

Huang, J. ;

Bass, J. ;

Wu, J. ;

Wang, C. ;

Fang, J. ;

Stewart, E. ;

Harstead, E. H. ;

Robinson, G. W. ;

Evans, W. E. ;

Pappo, A. ;

Zuo, J. ;

Relling, M. V. ;

Onar-Thomas, A. ;

Gajjar, A. ;

Stewart, C. F. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) :252-259

← 1 →